Recent News

• 02.10.2026 - Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
• 02.10.2026 - Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
• 01.22.2026 - Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
• 01.22.2026 - Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
• 01.21.2026 - Axogen Announces Proposed Public Offering of Common Stock
• 01.21.2026 - Axogen Announces Proposed Public Offering of Common Stock
• 01.12.2026 - Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
• 01.12.2026 - Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
• 12.17.2025 - Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
• 12.17.2025 - Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference

Recent Filings

• 01.23.2026 - 424B5 Prospectus [Rule 424(b)(5)]
• 01.23.2026 - 8-K Current report
• 01.23.2026 - EX-99.1 EX-99.1
• 01.21.2026 - S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
• 01.21.2026 - 424B5 Prospectus [Rule 424(b)(5)]
• 01.12.2026 - EX-99.1 EX-99.1
• 01.12.2026 - 8-K Current report
• 12.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.17.2025 - 4 Statement of changes in beneficial ownership of securities